BMI and serum lipid parameters predict increasing risk and aggressive prostate cancer in Chinese people

被引:13
作者
Zhao, Ruizhe [1 ,5 ]
Cheng, Gong [1 ]
Wang, Bing [4 ]
Qin, Chao [1 ]
Liu, Yun [3 ]
Pan, Yongsheng [1 ]
Wang, Jun [1 ]
Hua, Lixin [1 ]
Zhu, Weidong [2 ]
Wang, Zengjun [1 ]
机构
[1] Nanjing Med Univ, Dept Urol, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China
[2] Nanjing Univ, Dept Urol, Zhongda Hosp, Nanjing 210008, Peoples R China
[3] Nanjing Med Univ, Dept Geratol, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China
[4] Nanjing Med Univ, Dept Informat, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China
[5] Shanghai Jiao Tong Univ, Dept Urol, Peoples Hosp 1, Sch Med, Shanghai 200080, Peoples R China
关键词
prostate cancer; obesity; serum lipid parameters; risk; prognosis; BODY-MASS INDEX; POSTMENOPAUSAL BREAST-CANCER; FOLLOW-UP; METABOLIC SYNDROME; RADICAL PROSTATECTOMY; EMERGING ROLE; WEIGHT CHANGE; CHOLESTEROL; OBESITY; INSULIN;
D O I
10.18632/oncotarget.19790
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To determine if obesity and serum lipid parameters are associated with increased risk and more aggressive prostate cancer in Chinese population Materials and Methods: We conducted a retrospective cohort analysis including 3102 patients. Kruskal-Wallis test for continuous variables and the chi-squared tests for categorical variables were used for univariate comparison of the differences in patient characteristics across BMI categories between different groups. Odds ratios (OR) and 95% confidence intervals (CI) were estimated for the association between prostate cancer and the various patient characteristics. Multivariable Cox proportional hazards regression was performed to assess the risk of prostate cancer recurrence Results: 974 consecutive men were diagnosed as prostate cancer and 700 patients subsequently received radical prostatectomy immediately, and 1031 patients were pathologically diagnosed as biopsy negative. The level of low-density-lipoprotein cholesterol (LDL-c) and total cholesterol was significantly higher and the high-densitylipoprotein cholesterol (HDL-c) level is much lower in prostate cancer patients. Patients with low level of HDL-c, who subsequently received radical prostatectomy, had increased risk of high risk disease. In addition, patients with normal weight were less likely to develop a biochemical recurrence. Combined analysis revealed that obese patients had significantly higher rates of PSA recurrence over time than nonobese patients. Conclusions: In our study, lipid parameters are supposed to be associated with prostate cancer risk and aggressiveness. Obese men are at increased risk of PSA recurrence after radical prostatectomy.
引用
收藏
页码:66051 / 66060
页数:10
相关论文
共 60 条
[1]   Clinical performance of the Prostate Health Index (PHI) for the prediction of prostate cancer in obese men: data from the PROMEtheuS project, a multicentre European prospective study [J].
Abrate, Alberto ;
Lazzeri, Massimo ;
Lughezzani, Giovanni ;
Buffi, Nicolomaria ;
Bini, Vittorio ;
Haese, Alexander ;
de la Taille, Alexandre ;
McNicholas, Thomas ;
Palou Redorta, Joan ;
Gadda, Giulio M. ;
Lista, Giuliana ;
Kinzikeeva, Ella ;
Fossati, Nicola ;
Larcher, Alessandro ;
Dell'Oglio, Paolo ;
Mistretta, Francesco ;
Freschi, Massimo ;
Guazzoni, Giorgio .
BJU INTERNATIONAL, 2015, 115 (04) :537-545
[2]   Statin use and risk of prostate cancer: Results from a population-based epidemiologic study [J].
Agalliu, Ilir ;
Salinas, Claudia A. ;
Hansten, Philip D. ;
Ostrander, Elaine A. ;
Stanford, Janet L. .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 168 (03) :250-260
[3]   Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy [J].
Amling, CL ;
Riffenburgh, RH ;
Sun, L ;
Moul, JW ;
Lance, RS ;
Kusuda, L ;
Sexton, WJ ;
Soderdahl, DW ;
Donahue, TF ;
Foley, JP ;
Chung, AK ;
McLeod, DG .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) :439-445
[4]   Body size and prostate cancer: A 20-year follow-up study among 135006 Swedish construction workers [J].
Andersson, SO ;
Wolk, A ;
Bergstrom, R ;
Adami, HO ;
Engholm, G ;
Englund, A ;
Nyren, O .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (05) :385-389
[5]  
[Anonymous], UROL ONCOL
[6]   Modifiable risk factors for prostate cancer mortality in London: forty years of follow-up in the Whitehall study [J].
Batty, G. David ;
Kivimaeki, Mika ;
Clarke, Robert ;
Smith, George Davey ;
Shipley, Martin J. .
CANCER CAUSES & CONTROL, 2011, 22 (02) :311-318
[7]   Self-reported history of hypercholesterolaemia and gallstones and the risk of prostate cancer [J].
Bravi, F ;
Scotti, L ;
Bosetti, C ;
Talamini, R ;
Negri, E ;
Montella, M ;
Franceschi, S ;
La Vecchia, C .
ANNALS OF ONCOLOGY, 2006, 17 (06) :1014-1017
[8]   Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms [J].
Calle, EE ;
Kaaks, R .
NATURE REVIEWS CANCER, 2004, 4 (08) :579-591
[9]   International Variation in Prostate Cancer Incidence and Mortality Rates [J].
Center, Melissa M. ;
Jemal, Ahmedin ;
Lortet-Tieulent, Joannie ;
Ward, Elizabeth ;
Ferlay, Jacques ;
Brawley, Otis ;
Bray, Freddie .
EUROPEAN UROLOGY, 2012, 61 (06) :1079-1092
[10]   Serum immunoreactive leptin concentrations in normal-weight and obese humans [J].
Considine, RV ;
Sinha, MK ;
Heiman, ML ;
Kriauciunas, A ;
Stephens, TW ;
Nyce, MR ;
Ohannesian, JP ;
Marco, CC ;
McKee, LJ ;
Bauer, TL ;
Caro, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :292-295